Related Experiment Videos
[The blood coagulation aspects of acute infectious myocarditis]
Likars'Ka Sprava
|July 22, 1998
Insights
Infectious myocarditis patients often show early disseminated intravascular coagulation. Treatments targeting coagulation and inflammation improved hemostasis and clinical outcomes in these patients.
Area of Science:
- Cardiology
- Hematology
- Infectious Diseases
Background:
- Infectious myocarditis is a serious condition affecting heart muscle.
- Coagulation abnormalities are increasingly recognized in infectious myocarditis.
- Disseminated intravascular coagulation (DIC) may play a role in disease progression.
Purpose of the Study:
- To investigate coagulation profiles in patients with infectious myocarditis.
- To evaluate the impact of specific treatments on hemostasis and clinical status.
Main Methods:
- Studied 34 patients with infectious myocarditis.
- Utilized 9 distinct coagulation assays.
- Monitored patients undergoing treatment with coagulants, antiaggregants, or NSAIDs.
Main Results:
- A significant proportion of patients presented with Stage I disseminated intravascular coagulation (DIC).
- Treatment with coagulants, antiaggregants, and NSAIDs led to improved hemostasis markers.
- Observed positive dynamics in coagulative and thrombovascular hemostasis indices.
Conclusions:
- Stage I DIC is prevalent in infectious myocarditis.
- Therapeutic interventions targeting hemostasis correlate with clinical improvement in infectious myocarditis.
- Coagulation status is a critical factor in managing infectious myocarditis.
Abstract:
Overall thirty-four patients with infectious myocarditis were studied by 9 coagulation techniques. A major proportion of this patient population displayed stage I blood disseminated intravascular coagulation syndrome. Treatment with coagulants, antiaggregants or nonsteroid antiinflammatory drugs resulted in positive dynamics of indices for coagulative and thrombovascular hemostasis, which observation significantly correlated with clinical improvement.